{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-024877","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2022-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.814291+00:00","generated_at":"2026-06-23T00:35:26.066581+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ultralife Q3 rev up 53% to $33.2M; net loss narrows to $0.2M but gross margin slides","bullets":["Revenue $33.2M, up 53% YoY; net loss $0.2M ($0.01/share) vs loss $0.6M ($0.04) in Q3 2021.","Government/defense sales doubled YoY; backlog reached $106.2M, up 153% from prior year.","Gross margin fell to 20.2% from 23.5%, pressured by supply chain disruptions and cost inflation.","Battery & Energy Products revenue $28.6M (+43%); organic growth 8.5% after excluding Excell contribution.","Operating loss improved to $0.6M; adjusted EBITDA $1.3M (3.8% of sales) vs $0.3M (1.3%) a year ago."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-024877","json":"https://secwatch.observer/filing/0001437749-22-024877.json","markdown":"https://secwatch.observer/filing/0001437749-22-024877.md","text":"https://secwatch.observer/filing/0001437749-22-024877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774922024877/0001437749-22-024877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774922024877/ulbi20221025_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T00:35:26.066581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}